Will Top Super Bowl...
Health Care: Drugs
ADVENTRX Pharmaceuticals Inc. (ANX: AMEX)
$0.72 0.02 | 2.86%
02/07/12 - 04:00 PM ET
3.32M / 625.60K
Vol / Avg. Vol:0.72 / 0.70
Open / Prev. Close:0.70 - 0.75
Today's Range:0.56 - 4.21
52 Wk Range:18.64%
Performance YTD:TheStreet Rating:
Portfolios with ANX
- Portfolio NameUser Type
- Usertesting
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Trades for Seco...
- UserDusty's Tracker
- UserDustel's Growth Stocks
- UserOwn
- UserASCO 2010 Part 2
- UserCDBrevard Portfolio 1
- UserAlain's Portfolio
Latest ANX Headlines from TheStreet
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 11.11.11 | 08:11 am
- 5 Stocks Under $10 Setting Up to Trade Higher 09.15.11 | 01:09 pm
- 5 Stocks Setting Up to Break Out 09.09.11 | 03:09 pm
- ADVENTRX Stock Hits New 52-Week Low (ANX) 08.10.11 | 09:08 am
- Adventrx: FDA Rejects Lung Cancer Drug 08.10.11 | 07:08 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Sangamo Biosciences 07.22.11 | 05:07 am
- Biotech Stock Live Chat 07.15.11 | 12:07 pm
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
- More Hot Biotech Trades for Second Half 2011 07.12.11 | 06:07 am
Press Releases for ANX
- ADVENTRX Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 14 - PR Newswire 02.07.12 | 08:02 am
- Vista Partners Publishes February 2012 Newsletter - PR Newswire 02.02.12 | 09:02 am
- Vista Partners Updates Coverage On ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire 12.15.11 | 09:12 am
- ADVENTRX Meets With FDA To Discuss Development Plans For ANX-188 - PR Newswire 12.01.11 | 08:12 am
- ADVENTRX Announces Closing Of Public Offering - PR Newswire 11.16.11 | 03:11 pm
- ADVENTRX Prices Public Offering Of Stock - PR Newswire 11.11.11 | 08:11 am
- ADVENTRX Announces Public Offering Of Stock - PR Newswire 11.10.11 | 04:11 pm
- ADVENTRX And FDA Reach Agreement On Pivotal Study For ANX-514 - PR Newswire 10.26.11 | 08:10 am
- ADVENTRX Pharmaceuticals To Present At The 10th Annual BIOInvestor Forum Conference On October 26 - PR Newswire 10.19.11 | 08:10 am
- ADVENTRX Announces Results Of FDA Meeting To Discuss Exelbine NDA - PR Newswire 09.30.11 | 04:09 pm
Partner Headlines for ANX
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 12.19.11 | 09:12 am
- Why CytRx Corporation Is Still A Big Biotech 'If' Play - Seeking Alpha 12.14.11 | 09:12 am
- Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets - NASDAQ 12.07.11 | 06:12 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 12.02.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Company News for August 11, 2011 - Corporate Summary - Zacks 08.11.11 | 10:08 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.21.11 | 09:07 am
- Adventrx Pharmaceuticals: Undervalued Based on Product Approval Potential - Seeking Alpha 07.21.11 | 08:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
